• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

温度对米铂及顺铂碘油混悬液黏度影响的实验评估。

Experimental assessment of temperature influence on miriplatin and cisplatin iodized-oil suspension viscosity.

机构信息

Department of Radiology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan.

出版信息

Jpn J Radiol. 2013 Jun;31(6):424-7. doi: 10.1007/s11604-013-0201-0. Epub 2013 Mar 24.

DOI:10.1007/s11604-013-0201-0
PMID:23525952
Abstract

PURPOSE

To evaluate differences in the viscosity of a platinum iodized-oil suspension on the kind of platinum agent and temperature.

MATERIALS AND METHODS

Viscosities of a 70 mg miriplatin and 3.5 ml iodized-oil suspension (MO suspension) and that of 100 mg cisplatin and 10 ml iodized-oil suspension (CO suspension) were evaluated at three temperatures: 25, 37, and 50 °C. Iodized-oil was used as the control. Each liquid was injected into a capillary tube and allowed to drip separately. The liquid transit time was measured, and the viscosity of each liquid was calculated at each temperature.

RESULTS

The viscosity of each liquid decreased as the temperature increased: 43.3 ± 0.5, 39.2 ± 0.7, and 34.7 ± 0.6 mPa s for MO suspension, 41.3 ± 0.2, 36.9 ± 0.3, and 32.7 ± 0.9 mPa s for CO suspension, and 40.5 ± 0.2, 36.8 ± 0.2, and 33.8 ± 0.7 mPa s for iodized-oil at 25, 37, and 50 °C, respectively. The MO suspension group viscosity was significantly higher than that of the CO suspension group (p < 0.05) and the control (p < 0.05). Significant differences were found in viscosities among groups divided by temperature (25 °C-group vs. 37 °C-group, p < 0.05; 37 °C-group vs. 50 °C-group, p < 0.05).

CONCLUSION

The viscosity of the platinum iodized-oil suspension can be adjusted by changing temperature.

摘要

目的

评估不同铂制剂和温度对碘化油混悬液粘度的影响。

材料与方法

评估 70mg/miriplatin 和 3.5ml 碘化油混悬液(MO 混悬液)以及 100mg 顺铂和 10ml 碘化油混悬液(CO 混悬液)在三种温度(25、37 和 50°C)下的粘度。以碘化油作为对照。将每种液体注入毛细管并单独滴注。测量液体通过时间,并计算每种液体在每个温度下的粘度。

结果

每种液体的粘度随温度升高而降低:MO 混悬液分别为 43.3±0.5、39.2±0.7 和 34.7±0.6 mPa·s,CO 混悬液分别为 41.3±0.2、36.9±0.3 和 32.7±0.9 mPa·s,碘化油分别为 40.5±0.2、36.8±0.2 和 33.8±0.7 mPa·s,在 25、37 和 50°C 下。MO 混悬液组的粘度明显高于 CO 混悬液组(p<0.05)和对照组(p<0.05)。按温度分组的粘度存在显著差异(25°C 组与 37°C 组,p<0.05;37°C 组与 50°C 组,p<0.05)。

结论

通过改变温度可以调节铂碘化油混悬液的粘度。

相似文献

1
Experimental assessment of temperature influence on miriplatin and cisplatin iodized-oil suspension viscosity.温度对米铂及顺铂碘油混悬液黏度影响的实验评估。
Jpn J Radiol. 2013 Jun;31(6):424-7. doi: 10.1007/s11604-013-0201-0. Epub 2013 Mar 24.
2
Radiofrequency ablation after arterial injection of miriplatin-iodized oil suspension into swine liver: ablative zone size and tissue platinum concentration.在猪肝脏动脉注射米铂-碘化油混悬液后进行射频消融:消融区大小及组织铂浓度
Cardiovasc Intervent Radiol. 2014 Aug;37(4):1047-52. doi: 10.1007/s00270-013-0779-8.
3
Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.将米铂悬浮于油性淋巴造影剂中进行肝内动脉给药,可通过诱导铂 - DNA加合物形成和大量细胞凋亡来抑制植入大鼠肝脏的肿瘤生长。
Cancer Chemother Pharmacol. 2009 Aug;64(3):473-83. doi: 10.1007/s00280-008-0895-3. Epub 2008 Dec 24.
4
Short-term therapeutic effects of transcatheter arterial chemoembolization using miriplatin-lipiodol suspension for hepatocellular carcinoma.载米铂-碘油混悬剂经导管动脉化疗栓塞治疗肝细胞癌的近期疗效。
Jpn J Radiol. 2012 Nov;30(9):735-42. doi: 10.1007/s11604-012-0116-1. Epub 2012 Aug 28.
5
Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.经动脉注射米立培醇-碘油混悬剂联合射频消融(RFA)与微波消融(MWA)治疗小肝癌的疗效比较。
Jpn J Radiol. 2021 Apr;39(4):376-386. doi: 10.1007/s11604-020-01064-7. Epub 2020 Nov 4.
6
Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study.碘化油及碘化油乳剂肿瘤摄取的定量研究:实验性研究
Radiology. 1996 Dec;201(3):731-5. doi: 10.1148/radiology.201.3.8939223.
7
Comparison of the antitumor efficacy of transcatheter arterial chemoembolization with a miriplatin-iodized oil suspension and a cisplatin-iodized oil suspension for hepatocellular carcinoma.载米铂碘油混悬剂与顺铂碘油混悬剂经导管动脉化疗栓塞治疗肝癌的疗效比较。
Hepatol Res. 2013 Oct;43(10):1071-7. doi: 10.1111/hepr.12212. Epub 2013 Aug 19.
8
Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepatocellular carcinoma.硫代硫酸钠对经肝动脉用碘油-铂混悬液栓塞治疗肝细胞癌后顺铂清除的影响。
Acta Radiol. 2010 May;51(4):383-8. doi: 10.3109/02841850903563429.
9
Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).两种铂类药物(米立铂和精细粉末顺铂)抗肿瘤作用的比较。
Cardiovasc Intervent Radiol. 2012 Apr;35(2):399-405. doi: 10.1007/s00270-011-0172-4. Epub 2011 May 17.
10
Effects of temperature alteration on viscosity, polymerization, and in-vivo arterial distribution of N-butyl cyanoacrylate-iodized oil mixtures.温度变化对 N-丁基氰基丙烯酸酯-碘化油混合物的粘度、聚合和体内动脉分布的影响。
Jpn J Radiol. 2021 Nov;39(11):1111-1118. doi: 10.1007/s11604-021-01143-3. Epub 2021 Jun 9.

引用本文的文献

1
Combination Therapy by Transarterial Injection of Miriplatin-Iodized Oil Suspension with Microwave Ablation for Medium-Sized Hepatocellular Carcinoma: the Preliminary Experience.经动脉注射米铂-碘化油混悬液联合微波消融治疗中大型肝细胞癌的初步经验
Interv Radiol (Higashimatsuyama). 2022 Feb 4;7(1):1-8. doi: 10.22575/interventionalradiology.2021-0009. eCollection 2022 Mar 1.
2
Clinical utility of radiofrequency ablation following transarterial injection of miriplatin-iodized oil suspension in small hepatocellular carcinoma.经动脉注射米铂-碘化油混悬液后射频消融在小肝细胞癌中的临床应用价值
Jpn J Radiol. 2016 Sep;34(9):640-6. doi: 10.1007/s11604-016-0567-x. Epub 2016 Jul 25.
3

本文引用的文献

1
Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.经肝动脉灌注顺铂碘油乳剂化疗治疗不可切除的肝细胞癌的临床价值。
Anticancer Res. 2012 Nov;32(11):4923-30.
2
Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas.射频消融联合和不联合化疗栓塞治疗小肝癌的消融范围。
Jpn J Radiol. 2012 Aug;30(7):553-9. doi: 10.1007/s11604-012-0087-2. Epub 2012 May 19.
3
Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.
Improved efficacy of transcatheter arterial chemoembolization using warmed miriplatin for hepatocellular carcinoma.
使用温热米铂进行经动脉化疗栓塞治疗肝细胞癌的疗效改善。
Biomed Res Int. 2014;2014:359296. doi: 10.1155/2014/359296. Epub 2014 Sep 8.
4
Effect of transarterial chemoembolization with miriplatin plus epirubicin on local control of hepatocellular carcinoma: a retrospective comparison with miriplatin monotherapy.经动脉化疗栓塞术联合米立培南与表柔比星治疗肝细胞癌的局部控制效果:与米立培南单药治疗的回顾性比较。
Onco Targets Ther. 2013 Aug 1;6:1025-30. doi: 10.2147/OTT.S49443. eCollection 2013.
比较表柔比星联合丝裂霉素 C 与米瑞铂行超选择性经导管肝动脉化疗栓塞术对肝癌的局部控制效果。
Jpn J Radiol. 2012 Apr;30(3):263-70. doi: 10.1007/s11604-011-0043-6. Epub 2012 Jan 7.
4
A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma.一项使用 SM-11355(米立培南)进行经动脉化疗治疗肝细胞癌的随机 II 期临床试验。
Invest New Drugs. 2012 Oct;30(5):2015-25. doi: 10.1007/s10637-011-9776-4. Epub 2011 Dec 21.
5
Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).两种铂类药物(米立铂和精细粉末顺铂)抗肿瘤作用的比较。
Cardiovasc Intervent Radiol. 2012 Apr;35(2):399-405. doi: 10.1007/s00270-011-0172-4. Epub 2011 May 17.
6
Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma.经导管动脉内灌注化疗顺铂-碘油混悬剂治疗肝细胞癌。
J Gastroenterol. 2010;45(1):60-7. doi: 10.1007/s00535-009-0109-8. Epub 2009 Aug 5.
7
Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.碘油-顺铂在肝细胞癌经动脉导管栓塞术中的合适混合方法:缓释及蓄积特性评估
Hepatogastroenterology. 2008 Jan-Feb;55(81):202-6.
8
Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.早期肝细胞癌:射频消融联合化疗栓塞与肝切除术的比较
Radiology. 2008 Apr;247(1):260-6. doi: 10.1148/radiol.2471070818. Epub 2008 Feb 27.
9
Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.经动脉化疗栓塞术治疗不可切除肝细胞癌:随机对照试验的荟萃分析
Radiology. 2002 Jul;224(1):47-54. doi: 10.1148/radiol.2241011262.
10
In vitro release of SM-11355, cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)] platinum(II) suspended in lipiodol.
Biol Pharm Bull. 2000 May;23(5):637-40. doi: 10.1248/bpb.23.637.